Louisiana Medicaid Director Seth Gold's abrupt cancellation of $6 billion in contracts with Aetna and UnitedHealthcare on ...
The healthcare sector is a great place to find quality income stocks, and these two appear to be strong picks.
Legislators raised concerns about how the contract was set to end abruptly, potentially causing problems for patients.
Morgan Stanley also raised its price target to $93, pointing to a successful turnaround in CVS’s Health Care Benefits and Pharmacy & Consumer Wellness segments. RBC Capital maintained its Outperform ...
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders ...
Discover what mega-deals are, how they work, and see examples like the Sprint-T-Mobile merger. Learn how they impact ...
The Zacks Consensus Estimate for Centene’s 2026 earnings is pegged at $2.94 per share, indicating a 46.6% surge from the 2025 ...
StockStory.org on MSN
Winners and losers of Q3: Elevance Health (NYSE:ELV) vs the rest of the health insurance providers stocks
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health ...
Just a week after Gov. Jeff Landry’s administration confirmed the sudden end of a $4.2 billion Medicaid contract that ...
The Health Insurance Market value was US$ $$ billion in 2022. The Health Insurance Market value is forecast to reach US$ $$ billion by 2032, growing at a compound annual growth rate (CAGR) $% during ...
Millions of Medicare Part D enrollees will see substantial out-of-pocket savings as negotiated drug prices take effect in ...
Here are five ways AARP has fought to make lower drug prices a top priority. The 2003 law that created Medicare Part D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results